Orphan Designations For Pediatric Subgroups Of Common Diseases To End

US FDA's draft guidance closes loophole where sponsors could obtain an orphan designation for a pediatric subset and then be exempt from requirements to conduct pediatric studies.

FDAEntrance_1200x675

The US FDA plans to substantially curtail granting orphan designations for pediatric subpopulations in common diseases, in part to close a legal loophole discouraging clinical studies in the area.

FDA wrote in draft guidance issued Dec. 19 that it wants to stop a practice that allowed sponsors to...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA

More from Agency Leadership